CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −870 | $954.66 | $831K | 52,017 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −545 | $955.54 | $521K | 51,472 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −1,108 | $956.34 | $1.1M | 50,364 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −730 | $957.35 | $699K | 49,634 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −477 | $958.34 | $457K | 49,157 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −512 | $959.36 | $491K | 48,645 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −47 | $961.74 | $45K | 48,598 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −1 | $962.87 | $963 | 48,597 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −78 | $965.51 | $75K | 48,519 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −17 | $966.30 | $16K | 48,502 |
| 2024-03-14 | MURPHY ANDREW J EVP Research | Sale 10b5-1 | −196 | $968.20 | $190K | 48,306 |
| 2024-03-13 | MURPHY ANDREW J EVP Research | Option exercise 10b5-1 | +20,000 | $399.66 | $8.0M | 68,306 |
| 2024-03-13 | MURPHY ANDREW J EVP Research | Shares withheld for taxes 10b5-1 | −14,217 | $971.82 | $13.8M | 54,089 |
| 2024-03-13 | MURPHY ANDREW J EVP Research | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −20,000 | 20,000 | ||
| 2024-03-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −1 | $967.50 | $968 | 18,381 |
| 2024-03-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −1 | $968.66 | $969 | 18,380 |
| 2024-03-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −1 | $969.18 | $969 | 18,379 |
| 2024-03-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −4 | $970.38 | $4K | 18,375 |
| 2024-03-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −1 | $971.75 | $972 | 18,374 |
| 2024-03-01 | RYAN ARTHUR F Director | Sale 10b5-1 | −2 | $972.29 | $2K | 18,372 |
Page 32 of 49 · 971 trades